Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Neurology: Clinical Practice Accelerator
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

BCG and EBV status

  • Giovanni Ristori, Researcher, Center for Experimental Neurological Therapies, S. Andrea Hospital-site, Neurosciences, Mental Healtgiovanni.ristori@uniroma1.it
  • Giovanni Ristori, Rome, Italy; Silvia Romano, Rome, Italy; Giulia Coarelli, Rome, Italy; Maria Chiara Buscarinu, Rome, Italy; Marco Salvetti, Rome, Italy
Submitted February 19, 2014

We thank Dr. Brenner for his comments. Prevention of autoimmunity by adjuvant immunotherapy partially depends on inducible nitric oxide synthase [1] and the relationship between NOTCH-signaling and Epstein Barr Virus (EBV). It would be interesting to determine the mechanisms underlying the converging sero-epidemologic evidence that link EBV to MS. [2] This relationship is based on the molecular interaction between Epstein Barr Nuclear Antigen 2 (EBNA2) and Recombination Binding Protein for immunoglobulin kappa J region (RBP-Jk): EBNA2 functions as a transcriptional activator by interacting with DNA-binding RBP-Jk, and relieving the transcriptional repression that is mediated by a large multiprotein complex. [3] The EBNA2 gene is the most polymorphic of all EBV genes [4] and is densely targeted by host and virus micro-RNAs. [5] This interaction may be vital and MS studies on EBNA2 variants are ongoing. The possibility that adjuvant immunotherapy may counteract the pathogenic loop due to EBV or its genomic variants deserves further research. Moreover, future trials with BCG vaccine in demyelinating diseases might include analysis of EBV status (serology, viral load, genotyping) and NOTCH-signaling components.

1. Kahn DA, Archer DC, Gold DP, Kelly CJ. Adjuvant immunotherapy is dependent on inducible nitric oxide synthase. J Exp Med 2001;193:1261- 1268.

2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288-299.

3. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768.

4. Tierney RJ, Edwards RH, Sitki-Green D, et al. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J Infect Dis. 2006;193:287-297.

5. Skalsky RL, Corcoran DL, Gotwein E, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathogens 2012; 8: e1002484.

For disclosures, please contact the editorial office at journal@neurology.org.

Navigate back to article

Neurology: 100 (22)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise